John Wayne Cancer Institute ( Site 0049) — Santa Monica, California

Public research footprint of John Wayne Cancer Institute ( Site 0049), compiled from the ClinicalTrials.gov public registry.

108

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Melanoma · Prostate Cancer · Clear Cell Renal Cell Carcinoma (ccRCC) · Triple Negative Breast Cancer

Recently updated registry entries

NCT03425643 — Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as… (Active Not Recruiting)
NCT03972657 — A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in… (Recruiting)
NCT04291105 — Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at John Wayne Cancer Institute ( Site 0049)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.